The long-term effects of the neurotoxin l-trichloromethyl-1,2,3,4- tetrahydro-β-carboline (TaClo) on cognitive performance in rats

Journal of Neural Transmission, Supplementa

Volumn , Issue 72, 2007, Pages 149-154

  Sontag, T A ^a   Lange, K W ^a   Heim, Ch ^b   Kolasiewicz, W ^c   Tucha, O ^d   Sontag, K H ^b  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

^c POLISH ACADEMY OF SCIENCES   (Poland)

^d UNIVERSITY OF PLYMOUTH   (United Kingdom)

Author keywords

animal models; COGITAT; cognition; l trichloromethyl 1,2,3,4 tetrahydro beta carboline; Parkinson's disease; rat; spatial memory; TaClo

Indexed keywords

1 TRICHLOROMETHYL 1,2,3,4 TETRAHYDRO BETA CARBOLINE; 1-TRICHLOROMETHYL-1,2,3,4-TETRAHYDRO-BETA-CARBOLINE; CARBOLINE DERIVATIVE; NEUROTOXIN; UNCLASSIFIED DRUG;

ANIMAL; APPETITE; ARTICLE; DRUG EFFECT; EXPLORATORY BEHAVIOR; MALE; ORIENTATION; RAT; REACTION TIME; RECALL; WISTAR RAT;

ANIMALS; APPETITIVE BEHAVIOR; CARBOLINES; EXPLORATORY BEHAVIOR; MALE; MENTAL RECALL; NEUROTOXINS; ORIENTATION; RATS; RATS, WISTAR; REACTION TIME;

EID: 38449093717     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-211-73574-9_18     Document Type: Article

References (23)

1. Alexander GE, De Long MR, Strick PL (1986) Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 9:357-381
2. Bjorklund A, Lindvall O (1984) Dopamine-containing systems in the CNS. In: Bjorklund A, Hokfelt T (eds), Handbook of chemical neuroanatomy, Vol 2. Elsevier, Amsterdam, pp 55-122
3. Bringmann G, Feineis D, God R, Peters K, Peters EM, Scholz J, Riederer F, Moser A (2002) 1-Trichloromethyl-1, 2, 3, 4-tetrahydro-beta-carboline (TaClo) and related derivatives: chemistry and biochemical effects on catecholamine biosynthesis. Bioorg Med Chem 10:2207-2214
4. Bringmann G, God R, Feineis D, Janetzky B, Reichmann H (1995) TaClo as a neurotoxic lead: improved synthesis, stereochemical analysis, and inhibition of the mitochondrial respiratory chain. J Neural Transm Suppl 46:245-254
5. Brown RG, Marsden CD (1988) Internal versus external cues and the control of attention in Parkinson's disease. Brain 111(2):323345
6. Brozoski TJ, Brown RM, Rosvold HE, Goldman PS (1979) Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science 205:929-932
7. De Long MR (2000) Functional and pathophysiological models of the basal ganglia: therapeutic implications. Rinsho Shinkeigaku 40:1184
8. Divac I, Rosvold HE, Szwarcbart MK (1967) Behavioural effects of selective ablation of the caudate nucleus. J Comp Physiol Psychol 63:184-190
9. Gerlach M, Xiao AY, Heim C, Lan J, God R, Feineis D, Bringmann G, Riederer P, Sontag KH (1998) 1-Trichloromethyl-1, 2, 3, 4-tetrahydrobeta- carboline increases extracellular serotonin and stimulates hydroxyl radical production in rats. Neurosci Lett 257:17-20
10. Heim C, Pardowitz I, Sieklucka M, Kolasiewicz W, Sontag T, Sontag KH (2000) The analysis system COGITAT for the study of cognitive deficiencies in rodents. Behav Res Methods Instrum Comput 32:140-156
11. Janetzky B, God R, Bringmann G, Reichmann H (1995) 1-Trichloromethyl-1, 2, 3, 4-tetrahydro-beta-carboline, a new inhibitor of complex I. J Neural Transm Suppl 46:265-273
12. Javoy-Agid F, Agid Y (1980) Is the mesocortical dopaminergic system involved in Parkinson disease? Neurology 30:1326-1330
13. Kochen W, Kohlmuller D, De Biasi P, Ramsay R (2003) The endogeneous formation of highly chlorinated tetrahydro-beta-carbolines as a possible causative mechanism in idiopathic Parkinson's disease. Adv Exp Med Biol 527:253-263
14. Lange KW, Paul GM, Naumann M, Gsell W (1995) Dopaminergic effects on cognitive performance in patients with Parkinson's disease. J Neural Transm Suppl 46:423-432
15. Lange KW, Robbins TW, Marsden CD, James M, Owen AM, Paul GM (1992) L-dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction. Psychopharmacology (Berl) 107:394-404
16. Middleton FA, Strick PL (2000) Basal ganglia output and cognition: evidence from anatomical, behavioural, and clinical studies. Brain Cogn 42:183-200
17. Pahwa R, Paolo A, Troster A, Koller W (1998) Cognitive impairment in Parkinson's disease. Eur J Neurol 5:431-441
18. Pothos EN, Hernandez L, Hoebel BG (1995) Chronic food deprivation decreases extracellular dopamine in the nucleus accumbens: implications for a possible neurochemical link between weight loss and drug abuse. Obes Res 3 Suppl 4:525S-529S
19. Rausch WD, Abdel-mohsen M, Koutsilieri E, Chan WW, Bringmann G (1995) Studies of the potentially endogenous toxin TaClo (1-trichloromethyl-1, 2, 3, 4-tetrahydro-beta-carboline) in neuronal and glial cell cultures. J Neural Transm Suppl 46:255-263
20. Riederer P, Foley P, Bringmann G, Feineis D, Bruckner R, Gerlach M (2002) Biochemical and pharmacological characterization of 1-trichloromethyl-1, 2, 3, 4-tetrahydro-beta-carboline: a biologically relevant neurotoxin? Eur J Pharmacol 442:1-16
21. Sontag KH, Heim C, Sontag TA, God R, Reichmann H, Wesemann W, Rausch WD, Riederer P, Bringmann G (1995) Long-term behavioural effects of TaClo (1-trichloromethyl-1, 2, 3, 4-tetrahydro-beta-carboline) after subchronic treatment in rats. J Neural Transm Suppl 46:283-289
22. Taylor AE, Saint-Cyr JA (1995) The neuropsychology of Parkinson's disease. Brain Cogn 28:281-296
23. Zgaljardic DJ, Borod JC, Foldi NS, Mattis P (2003) A review of the cognitive and behavioural sequelae of Parkinson's disease: relationship to frontostriatal circuitry. Cogn Behav Neurol 16:193-210